The utilisation of tools to facilitate cross-border communication during international food safety events, 1995-2020: a realist synthesis
Savelli, Carmen Joseph, Garcia Acevedo, Raul Fernando, Simpson, Jane, Mateus, Céu
Published in Globalization and health (24.06.2021)
Published in Globalization and health (24.06.2021)
Get full text
Journal Article
Neoadjuvant rectal cancer (RC) score to predict survival: Potential surrogate endpoint for early-phase trials
Yothers, Greg, George, Thomas J., Petrelli, Nicholas J., O'Connell, Michael J., Beart, Robert W., Allegra, Carmen Joseph, Roh, Mark S., Lopa, Samia H., Sharif, Saima, Wolmark, Norman
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors
Chatzkel, Jonathan Alexander, Lee, Ji-Hyun, Ali, Azka, Allegra, Carmen Joseph, Brisbane, Wayne, Crispen, Paul, O'Malley, Padraic, George, Thomas J., Ramnaraign, Brian Hemendra
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
NSAB C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease
Salem, Mohamed E., Huggins-Puhalla, Shannon Leigh, George, Thomas J., Allegra, Carmen Joseph, Palomares, Melanie R., Baehner, Frederick L, Wolmark, Norman
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in castrate-resistant prostate cancer and certain other immunologically cold tumors
Chatzkel, Jonathan Alexander, Lee, Ji-Hyun, ali, azka, Allegra, Carmen Joseph, Crispen, Paul, Jones, Dennie V., O'Malley, Padraic, George, Thomas J., Ramnaraign, Brian Hemendra
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (g BRCA 1/2+) pathogenic variants: SWOG S2001
Chung, Vincent, Guthrie, Katherine A, Pishvaian, Michael J, Reiss, Kim Anna, Lowy, Andrew M., Sohal, Davendra, Colby, Sarah, Sharon, Elad, Allegra, Carmen Joseph, O'Reilly, Eileen Mary, Chiorean, E. Gabriela, Philip, Philip Agop
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase II study of M6620 and irinotecan in TP53 mutant gastric and gastroesophageal junction (GEJ) adenocarcinoma patients (pts) [NCT03641313]
Das, Satya, Whisenant, Jennifer, Doyle, Austin, Allegra, Carmen Joseph, Berlin, Jordan
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
NSABP C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease
Salem, Mohamed E., Puhalla, Shannon L, George, Thomas J., Allegra, Carmen Joseph, Arrick, Bradley A., Palomares, Melanie R., Chung, Ki Y., McCormack, Michael Joseph, Shipstone, Asheesh, Baehner, Frederick L., Wolmark, Norman
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
A phase Ib/II study of atezolizumab plus tivozanib in pancreatic, gallbladder, and bile duct malignancies
Ramnaraign, Brian Hemendra, Lee, Ji-Hyun, Ali, Azka, Rogers, Sherise C., Fabregas, Jesus C., Thomas, Ryan M., Allegra, Carmen Joseph, DeRemer, David L., George, Thomas J., Chatzkel, Jonathan Alexander
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
NSABP FC-10: A phase Ib study of pembrolizumab (pembro) in combination with pemetrexed (pem) and oxaliplatin (oxali) in patients with chemo-refractory metastatic colorectal cancer (mCRC)
Krauss, John C., Yothers, Greg, George, Thomas J., Wade, James Lloyd, Basu Mallick, Atrayee, Lee, James J., Huggins-Puhalla, Shannon Leigh, Allegra, Carmen Joseph, Jacobs, Samuel A., Wolmark, Norman
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
NSABP FC-11: A phase II study of neratinib (N) plus trastuzumab (T) or N plus cetuximab (C) in patients (pts) with "quadruple wild-type" metastatic colorectal cancer (mCRC) based on HER2 status
Jacobs, Samuel A., George, Thomas J., Kolevska, Tatjana, Wade, James Lloyd, Zera, Richard, Buchschacher, Gary L, Al Baghdadi, Tareq, Shipstone, Asheesh, Lin, Daniel, Yothers, Greg, Pogue-Geile, Katherine L., Huggins-Puhalla, Shannon Leigh, Allegra, Carmen Joseph, Wolmark, Norman
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer: NSABP FR-2
George, Thomas J., Yothers, Greg, Lee, James J., Deutsch, Melvin, Jacobs, Samuel A., Allegra, Carmen Joseph, Wolmark, Norman
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
A phase Ib/II study (IMMCO-1) of atezolizumab plus tivozanib in immunologically cold pancreatic, gallbladder, and biliary cancers
Ramnaraign, Brian Hemendra, Lee, Ji-Hyun, ali, azka, Rogers, Sherise C., Fabregas, Jesus C., Thomas, Ryan M., Allegra, Carmen Joseph, Sahin, Ilyas, DeRemer, David L., George, Thomas J., Chatzkel, Jonathan Alexander
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article